Cinctive Capital Management LP Purchases Shares of 51,679 HealthEquity, Inc. (NASDAQ:HQY)

Cinctive Capital Management LP bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 51,679 shares of the company's stock, valued at approximately $4,959,000. Cinctive Capital Management LP owned about 0.06% of HealthEquity as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Smartleaf Asset Management LLC increased its position in HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after buying an additional 98 shares during the period. Louisiana State Employees Retirement System grew its stake in shares of HealthEquity by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock valued at $2,322,000 after acquiring an additional 100 shares in the last quarter. Oregon Public Employees Retirement Fund increased its position in HealthEquity by 0.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock worth $1,706,000 after acquiring an additional 100 shares during the period. State of Michigan Retirement System raised its stake in HealthEquity by 0.5% in the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock worth $1,988,000 after purchasing an additional 100 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in HealthEquity by 0.6% in the 4th quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company's stock valued at $1,850,000 after purchasing an additional 106 shares during the period. Institutional investors own 99.55% of the company's stock.

Remove Ads

HealthEquity Price Performance

Shares of NASDAQ HQY traded down $0.62 during mid-day trading on Tuesday, hitting $79.74. 465,925 shares of the stock traded hands, compared to its average volume of 743,691. The company has a market cap of $6.90 billion, a PE ratio of 73.64, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm has a 50 day simple moving average of $101.18 and a two-hundred day simple moving average of $96.48.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 2.20% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently commented on HQY. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price target for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. JMP Securities lifted their price objective on HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a report on Tuesday, December 10th. The Goldman Sachs Group cut their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Barrington Research restated an "outperform" rating and issued a $112.00 price target on shares of HealthEquity in a research report on Friday, March 14th. Finally, Royal Bank of Canada upped their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research report on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, HealthEquity currently has an average rating of "Buy" and a consensus price target of $112.58.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.